Husky Technologies, a global leader in injection molding solutions, has announced the acquisition of secondary injection unit and rotary platen technologies from MGS Healthcare Manufacturing (MGS). MGS, a provider of healthcare manufacturing solutions, has transferred its Multishot product line to Husky as part of a strategic move to focus more on its healthcare contract development and manufacturing services.
This acquisition allows Husky to integrate MGS’s precision secondary injection units and rotary platens with its existing Altanium® mold controller technology. The integration of these advanced multi-shot technologies is expected to enhance Husky’s ability to offer comprehensive, high-performance, turn-key solutions. The addition strengthens Husky’s capabilities in producing multi-material and multi-color applications, which are crucial in industries such as medical, packaging, and consumer electronics.
“This acquisition reinforces our commitment to innovation and excellence,” said Robert Domodossola, President of Systems and Tooling at Husky Technologies. “By bringing these complementary technologies into our portfolio, we are enhancing our ability to serve customers with integrated, high-performance solutions that drive efficiency and growth.”
Shawn Krenke, Chief Technology Officer at MGS, also commented on the deal: “MGS is pleased to announce the divestiture of its Multishot product line to Husky. As a global leader in injection molding technology and a key strategic supplier to MGS, Husky is the ideal organization to take over and continue advancement of the Multishot product line.”
Husky plans to showcase the new technologies at the Plastics Technology XPO in Illinois from March 18-20, 2025. The acquisition reflects Husky’s ongoing efforts to provide innovative, integrated solutions to its global customer base.